Skip to main content
. 2021 Nov 22;14(11):1196. doi: 10.3390/ph14111196

Figure 9.

Figure 9

Clinical Trial of MLR-1023 vs. placebo. The study was a randomized double-blinded placebo-controlled parallel-arm phase II trial to investigate the effect of MLR-1023 on body weight in adults with type 2 diabetes. Body weight was measured at baseline, at day 29, and at day 36. Values are mean ± SEM. * p < 0.05. ** p < 0.01.